• EdU Imaging Kits: Reading S-Phase in RCC

  2026-09-05

  EdU Imaging Kits (HF488) provide a precise way to interpret DNA synthesis in renal cell carcinoma models. This article connects EdU click chemistry with the esculin RCC study and offers a practical framework for microscopy, flow cytometry, and orthogonal validation.

• PPT and ERα: From Selective Signal to Translation

  2026-09-05

  PPT (Propyl Pyrazole Triol) provides a precise way to perturb ERα while minimizing ERβ-driven ambiguity. This thought-leadership article connects its receptor-level pharmacology with the FOXM1–ERα network reported in female lung adenocarcinoma and offers a practical framework for translational validation.

• Cyclic di-GMP: From Signal to Assay Design

  2026-09-04

  Cyclic di-GMP is an intracellular second messenger linking bacterial persistence biology with STING-centered immune modulation research. This article focuses on stage-resolved assay design, causal interpretation, and the practical limits of translating bacterial findings into cancer immunotherapy studies.

• Z-VEID-FMK: Caspase-6 Inhibitor Workflow

  2026-09-04

  Z-VEID-FMK is a cell-permeable, irreversible caspase-6 inhibitor for separating caspase-6-dependent proteolysis from broader apoptotic effects. This workflow connects practical apoptosis assays with a viral immune-evasion model involving PRRSV N-protein cleavage, while emphasizing controls, timing, and interpretation.

• V5 Epitope Tag Peptide: Workflow Guide

  2026-09-03

  Build more reliable recombinant-protein detection workflows with the V5 Epitope Tag Peptide as a sequence-specific competition control, assay calibrator, and purification aid. The guide connects routine Western blotting and immunoprecipitation with antibody-kinetic insights from single-molecule microscopy, while emphasizing practical controls and troubleshooting.

• Dual Luciferase Reporter Gene System for BMSC Studies

  2026-09-02

  Apply the Dual Luciferase Reporter Gene System to separate pathway-dependent transcriptional effects from sample-to-sample variability in BMSC research. This workflow combines firefly/Renilla normalization, no-lysis mammalian cell detection, and practical controls for studying MRF–FSHR–cAMP-PKA-CREB regulation.

• SAR131675: A VEGFR-3 Assay Strategy

  2026-09-02

  Explore SAR131675, a selective VEGFR-3 inhibitor, through a practical framework linking kinase selectivity, endothelial phenotypes, and the VEGFC–macrophage axis in hepatic fibrosis research.

• KN-62: Designing Causal Calcium Signaling Assays

  2026-09-02

  KN-62 is a selective CaMKII inhibitor for separating kinase-dependent signaling from direct calcium-channel effects. This guide builds a causal assay framework from neuronal channel pharmacology, with practical guidance for secretion, metabolism, and cell-cycle studies.

• E-64 for Cysteine Protease Assays

  2026-09-01

  E-64 provides irreversible, nanomolar-range cysteine protease inhibition for enzyme kinetics, lysate validation, and mechanism-focused cell studies. This guide shows how to use it as a biochemical control while avoiding common interpretation errors in cathepsin, calpain, and papain-like protease workflows.

• NP-40 Lysis Buffer for Translational Neuroimmunology

  2026-08-31

  A mechanistic and workflow-focused perspective on how non-denaturing protein extraction can strengthen FPR2/ALX, microglia, NK-cell, and SYK-AKT studies in autoimmune astrocytopathy.

• ConA Targets Conserved Coronavirus Spike Glycans

  2026-08-31

  This study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. By combining fusion, pseudovirus, authentic infection, biochemical, and mouse experiments, the authors show that concanavalin A can block spike activation and reduce hCoV-NL63 disease in vivo.

• Difloxacin HCl: Assay Design Beyond MIC

  2026-08-30

  Difloxacin HCl supports both bacterial susceptibility studies and multidrug resistance reversal research. This article presents an assay-design framework that separates antibacterial phenotypes from transporter-related cellular effects and applies mechanistic lessons from mitotic checkpoint research.

• PA–Src–FAK–ROCK Signaling in Decidualization

  2026-08-29

  A 2025 FEBS Journal study identifies a phosphatidic acid–Src–FAK–RhoA/ROCK pathway that drives cytoskeletal remodeling during human endometrial stromal cell decidualization. Its key contribution is to distinguish morphology-linked signaling from canonical decidual markers and to connect the in vitro mechanism with uterine changes in ovariectomized mice.

• Nitrocefin and the Next Era of β-Lactamase Research

  2026-08-28

  Nitrocefin connects enzyme mechanism, resistance phenotyping, and translational decision-making. This thought-leadership guide shows how its colorimetric signal can strengthen β-lactamase characterization while clarifying the limits of assay-based inference.

• Gallein: G Protein βγ Subunit Inhibitor Guide

  2026-08-28

  Gallein is a G protein βγ subunit inhibitor for experimentally dissecting GPCR signaling pathway outputs. Product and model data support applications in cancer metastasis inhibition, macrophage polarization modulation, and an autoimmune myocarditis treatment model, while a 2026 Cell Research study provides a related but distinct GPR81 metabolic signaling context.

8454 records 1/564 page Next 12345 下5页 Last page